Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 24

    AIIMS director kickstarts three day International Conference at Delhi Pharmaceutical Sciences and Research University

    AIIMS director kickstarts three day International Conference at Delhi Pharmaceutical Sciences and Research University

    Medical Dialogues Bureau23 Feb 2020 12:00 PM IST
    New Delhi: Delhi Pharmaceutical Sciences and Research University (DPSRU) is hosting a three day International Conference of Cardiovascular Sciences-...
    Following SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinations

    Following SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinations

    MD bureau23 Feb 2020 11:45 AM IST
    New Delhi: In continuation of the series of directives that the FDC Division, Central Drugs Standard Control Organization (CDSCO), Directorate General...
    FDA approves Lundbecks intravenous migraine prevention drug Vyepti, to launch in April 2020

    FDA approves Lundbeck's intravenous migraine prevention drug Vyepti, to launch in April 2020

    Medical Dialogues Bureau23 Feb 2020 11:30 AM IST
    Deerfield: Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) has been approved by the U.S. Food and Drug Administration (FDA) for the preventive...
    Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for Management of Postoperative Pain

    Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for Management of Postoperative Pain

    Medical Dialogues Bureau23 Feb 2020 9:30 AM IST
    SAN DIEGO : Heron Therapeutics, Inc,. a commercial-stage biotechnology company focused on improving the lives of patients by developing...
    Strides Consumer forays into North India market

    Strides Consumer forays into North India market

    Medical Dialogues Bureau22 Feb 2020 4:29 PM IST
    As part of the foray, the company has launched two products -- Nixit, and oral nicotine replacement therapy (NRT) product, and Jointflex, a topical...
    With USFDA approval in Hand, Esperion to launch Non-Statin Cholesterol drug NEXLETOL  for as low as 10 dollars

    With USFDA approval in Hand, Esperion to launch Non-Statin Cholesterol drug NEXLETOL for as low as 10 dollars

    Medical Dialogues Bureau22 Feb 2020 4:10 PM IST
    Eligible patients in the USA with commercial drug insurance coverage for NEXLETOL may pay as little as $10 per fill, up to a 3-month supply.
    Top Cos in pharmaceutical supply chain develop Blockchain system to track prescription drugs, stop counterfeit

    Top Cos in pharmaceutical supply chain develop Blockchain system to track prescription drugs, stop counterfeit

    Medical Dialogues Bureau22 Feb 2020 4:04 PM IST
    Among the 24 participating companies are Amgen Inc, FedEx Corp, GlaxoSmithKline Plc, Novartis, AmerisourceBergen Corp , Sanofi ), Walgreens Boots...
    Eli Lilly Completes Acquisition of Dermira

    Eli Lilly Completes Acquisition of Dermira

    Medical Dialogues Bureau22 Feb 2020 9:45 AM IST
    INDIANAPOLIS : Eli Lilly and Company has announced the successful completion of its acquisition of Dermira, Inc. (NASDAQ: DERM). The acquisition...
    ICRA revises domestic pharma industry outlook to negative due to coronavirus outbreak

    ICRA revises domestic pharma industry outlook to negative due to coronavirus outbreak

    Medical Dialogues Bureau21 Feb 2020 12:22 PM IST
    According to Icra research, domestic API manufacturers have an inventory of one-two months, which should adequately support their production till...
    Serum Institute to come up with coronavirus vaccine by 2022

    Serum Institute to come up with coronavirus vaccine by 2022

    Medical Dialogues Bureau21 Feb 2020 12:13 PM IST
    The vaccine candidate, developed by SII in partnership with American biotechnology firm Codagenix, has progressed to the pre-clinical test phase (the...
    Niti Aayog meets Top pharma execs to find ways to mitigate coronavirus impact; DoP seeks export ban on 12 APIs

    Niti Aayog meets Top pharma execs to find ways to mitigate coronavirus impact; DoP seeks export ban on 12 APIs

    Medical Dialogues Bureau21 Feb 2020 11:58 AM IST
    The meeting was attended by Biocon's Kiran Mazumdar Shaw, Zydus' Pankaj Patel and Dr Reddy's Laboratories' Satish Reddy and other top pharma execs
    Anglo-French co Novacyt  launches CE-IVD Marked novel coronavirus diagnostics test

    Anglo-French co Novacyt launches CE-IVD Marked novel coronavirus diagnostics test

    Medical Dialogues Bureau20 Feb 2020 3:16 PM IST
    Paris, France and Camberley: Novacyt an international specialist in clinical diagnostics recently announced that its molecular diagnostics...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok